Partner or Speaker Highlights

Connecting with patients and families during COVID-19 – Part 1

Issues around Paxlovid – Part 1 Modern Practice Podcast

Available through an FDA Emergency Use Authorization (EUA), Paxlovid could be a approach to more effective treatment of the COVID-19 virus. On this episode, we begin a two-part discussion about the evidence from clinical trials of Paxlovid.   Guest speaker: Stacy Lauderdale, PharmD, BCPS Senior Director, Drug Information Vizient   Moderator: Tomas Villanueva, DO, MBA, FACPE, SFHM Senior Principal, Clinical Operations and Quality Vizient   Show Notes: [01:09] Defining Paxlovid [01:53] Paxlovid vs Tamiflu – comparison of effectiveness and impact [02:50] Two randomized control trials [04:42] Effectiveness with Omicron variant [07:19] Age as a risk factor [08:23] The issue of rebound   Links | Resources: To contact Modern Practice: Stacy’s email address: 13 Things to Know about Paxlovid, the Latest COVID-19 Pill (Yale Medicine) Click here   Subscribe Today! Apple Podcasts Amazon Podcasts Android Google Podcasts Spotify Stitcher RSS Feed
  1. Issues around Paxlovid – Part 1
  2. To boost or not to boost – Part 2
  3. To boost or not to boost – Part 1
  4. The monkeypox epidemic – Part 2
  5. The monkeypox epidemic – Part 1

 How do you increase patient satisfaction and meet patient demands? How do you involve connecting with patients and families?

Patient Family Engagement is a critical aspect of care, especially now in the wake of COVID-19.

Listen to Kellie Goodson, our partner, talk about connection and patient satisfaction

Leave a Reply